{"id":194099,"date":"2026-01-16T07:17:23","date_gmt":"2026-01-16T06:17:23","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/"},"modified":"2026-01-16T07:17:23","modified_gmt":"2026-01-16T06:17:23","slug":"stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/","title":{"rendered":"Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-jmc6.jpg\" \/><\/p>\n<p>El Servicio de Cardiolog\u00eda del\u00a0<a href=\"https:\/\/www.hospitalsonespases.es\/\" rel=\"noopener\">Hospital Universitario Son Espases<\/a> y el <a href=\"https:\/\/www.idisba.es\/\" target=\"_blank\" rel=\"noopener\">Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa)<\/a> han participado en el seguimiento ampliado del ensayo controlado aleatorizado SUGAR sobre los stents liberadores de anfilimus versus liberadores de zotarolimus en pacientes con diabetes mellitus y enfermedad coronaria.<\/p>","protected":false},"excerpt":{"rendered":"<p>El Servicio de Cardiolog\u00eda del\u00a0Hospital Universitario Son Espases y el Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa) han participado en el seguimiento ampliado del ensayo controlado aleatorizado SUGAR sobre los stents liberadores de anfilimus versus liberadores de zotarolimus en pacientes con diabetes mellitus y enfermedad coronaria.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-194099","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.9 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria\" \/>\n<meta property=\"og:description\" content=\"El Servicio de Cardiolog\u00eda del\u00a0Hospital Universitario Son Espases y el Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa) han participado en el seguimiento ampliado del ensayo controlado aleatorizado SUGAR sobre los stents liberadores de anfilimus versus liberadores de zotarolimus en pacientes con diabetes mellitus y enfermedad coronaria.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-16T06:17:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-jmc6.jpg\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria\",\"datePublished\":\"2026-01-16T06:17:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/\"},\"wordCount\":62,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-jmc6.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/\",\"name\":\"Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-jmc6.jpg\",\"datePublished\":\"2026-01-16T06:17:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-jmc6.jpg\",\"contentUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-jmc6.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/","og_locale":"es_ES","og_type":"article","og_title":"Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria","og_description":"El Servicio de Cardiolog\u00eda del\u00a0Hospital Universitario Son Espases y el Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa) han participado en el seguimiento ampliado del ensayo controlado aleatorizado SUGAR sobre los stents liberadores de anfilimus versus liberadores de zotarolimus en pacientes con diabetes mellitus y enfermedad coronaria.","og_url":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/","og_site_name":"bip4ex","article_published_time":"2026-01-16T06:17:23+00:00","og_image":[{"url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-jmc6.jpg","type":"","width":"","height":""}],"author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria","datePublished":"2026-01-16T06:17:23+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/"},"wordCount":62,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-jmc6.jpg","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/","url":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/","name":"Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/#primaryimage"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-jmc6.jpg","datePublished":"2026-01-16T06:17:23+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/#primaryimage","url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-jmc6.jpg","contentUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-jmc6.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/stents-con-anfilimus-vs-zotarolimus-en-pacientes-diabeticos-con-cardiopatia-coronaria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Stents con anfilimus vs zotarolimus en pacientes diab\u00e9ticos con cardiopat\u00eda coronaria"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/194099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=194099"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/194099\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=194099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=194099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=194099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}